Pharming Group N.V. (PHGUF)
USD 0.84
(0.0%)
USD 0.84
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 245.31 Million | 205.62 Million | 189.85 Million | 228.39 Million | 189.33 Million | 154.57 Million |
| Cost of Revenue | 25.21 Million | 17.56 Million | 20.18 Million | 25.33 Million | 23.92 Million | 25.37 Million |
| Gross Profit | 220.1 Million | 188.06 Million | 169.67 Million | 203.05 Million | 165.41 Million | 129.2 Million |
| Operating Expenses | 225.49 Million | 169.82 Million | 156.72 Million | 120.97 Million | 97.18 Million | 85.74 Million |
| Selling, General and Administrative Expenses | 87.5 Million | 131.81 Million | 92.04 Million | 69.96 Million | 65.89 Million | 46.83 Million |
| Research and Development Expenses | 68.91 Million | 52.53 Million | 67.17 Million | 41.46 Million | 31.77 Million | 33.03 Million |
| Other Expenses | 69.07 Million | -14.52 Million | -2.5 Million | 9.53 Million | -487.27 Thousand | - |
| Cost and Expenses | 250.7 Million | 187.38 Million | 176.9 Million | 146.3 Million | 121.1 Million | 111.11 Million |
| Operating Income | -4.87 Million | 18.23 Million | 27.83 Million | 82.08 Million | 68.22 Million | 43.45 Million |
| Interest Expense | 5.96 Million | 5.35 Million | 5.91 Million | 6.39 Million | 13.34 Million | 16.37 Million |
| Income Tax Expense | -1.46 Million | 1.31 Million | 6.76 Million | 6.83 Million | 11.74 Million | -27.6 Million |
| Earnings before Tax | -12.01 Million | 14.98 Million | 22.03 Million | 47.46 Million | 52.28 Million | 980.32 Thousand |
| Net Income | -10.54 Million | 13.67 Million | 15.99 Million | 37.74 Million | 40.55 Million | 28.58 Million |
| Earnings Per Share Basic | -0.02 | 0.02 | 0.02 | 0.06 | 0.06 | 0.05 |
| Earnings Per Share Diluted | -0.02 | 0.02 | 0.02 | 0.06 | 0.06 | 0.04 |
| Weighted Average Shares Outstanding | 657.02 Million | 719.68 Million | 695.5 Million | 682.73 Million | 664.86 Million | 606.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 657.02 Million | 719.68 Million | 701.15 Million | 682.73 Million | 673.51 Million | 653.52 Million |
| Gross Margin | 0.90 | 0.91 | 0.89 | 0.89 | 0.87 | 0.84 |
| EBIT Margin | 0.04 | 0.16 | 0.25 | 0.40 | 0.40 | 0.33 |
| Profit Margin | -0.04 | 0.07 | 0.08 | 0.17 | 0.21 | 0.18 |
| EBITDA | 9.87 Million | 33.53 Million | 48.77 Million | 92.11 Million | 71.45 Million | 50.98 Million |
| Earnings Before Tax Margin | -0.02 | 0.09 | 0.15 | 0.36 | 0.36 | 0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 75.86 Million | 73.72 Million | 55.26 Million | 83.33 Million | 245.31 Million | 66.66 Million |
| Cost of Revenue | 6.91 Million | 7.95 Million | 8.33 Million | 15.04 Million | 25.21 Million | 8.29 Million |
| Gross Profit | 68.95 Million | 65.76 Million | 46.92 Million | 68.29 Million | 220.1 Million | 58.36 Million |
| Operating Expenses | 65.57 Million | 69.74 Million | 63.48 Million | 67.68 Million | 242.1 Million | 56.45 Million |
| Selling, General and Administrative Expenses | 44.57 Million | 48.25 Million | 45.07 Million | 55.77 Million | - | 36 Million |
| Research and Development Expenses | 21 Million | 21.49 Million | 18.41 Million | 11.9 Million | - | 20.75 Million |
| Other Expenses | - | -912 Thousand | - | - | 286 Thousand | - |
| Cost and Expenses | 72.48 Million | 77.7 Million | 71.82 Million | 82.72 Million | 267.31 Million | 64.75 Million |
| Operating Income | 3.37 Million | -3.97 Million | -16.55 Million | 615.79 Thousand | -5.38 Million | 1.9 Million |
| Interest Expense | 3.03 Million | 1.97 Million | 1.55 Million | 1.34 Million | 5.96 Million | 1.65 Million |
| Income Tax Expense | 2.58 Million | 1.09 Million | -4.15 Million | 718.43 Thousand | -1.46 Million | -157 Thousand |
| Earnings before Tax | 1.98 Million | 298.49 Thousand | -15.99 Million | -2.77 Million | -12.01 Million | 3.3 Million |
| Net Income | -1.04 Million | -1.19 Million | -12.37 Million | -2.77 Million | -10.54 Million | 3.46 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.02 | -0.00 | - | 0.01 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.02 | -0.00 | - | 0.01 |
| Weighted Average Shares Outstanding | 678.35 Million | 678.35 Million | 671.07 Million | 671.07 Million | 657.02 Million | 656.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 678.35 Million | 678.35 Million | 671.07 Million | 671.07 Million | 725.46 Million | 656.34 Million |
| Gross Margin | 0.91 | 0.89 | 0.85 | 0.82 | 0.90 | 0.88 |
| EBIT Margin | 0.10 | -0.06 | -0.19 | 0.10 | - | 0.12 |
| Profit Margin | -0.01 | -0.02 | -0.22 | -0.03 | -0.04 | 0.05 |
| EBITDA | 7.8 Million | -4.24 Million | -10.67 Million | 8.36 Million | - | 7.86 Million |
| Earnings Before Tax Margin | 0.04 | -0.05 | -0.30 | 0.01 | -0.02 | 0.03 |
6807
2208
FBK
601666
SCND
UNSP